ME
NASDAQ · MENS
Jyong Biotech Ltd. Ordinary Shares
Healthcare · Biotechnology
$2.06
Up+$0.02 (+0.98%)
Updated Aug 14, 2026, 3:06 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.04B
- P/E ratio
- -813.48
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $3.00
- Volume
- 17.13K
- Avg. volume
- 352K
Price performance
MENS price history
1M range · 21 trading sessions · Daily adjusted prices
MENS closed at $2.06 after 21 trading sessions, down 10.43% for the selected period.
- Last close
- $2.06
- Period change
- -10.43%
- Period low
- $2.00
- Period high
- $2.71
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $2.06 | $2.15 | $2.035 | $2.06 | 17.13K |
| Aug 12, 2026 | $2.138 | $2.18 | $2.0201 | $2.04 | 32.56K |
| Aug 11, 2026 | $2.148 | $2.19 | $2.01 | $2.10 | 35.26K |
| Aug 10, 2026 | $2.00 | $2.12 | $2.00 | $2.10 | 23.55K |
| Aug 7, 2026 | $2.04 | $2.08 | $1.97 | $2.03 | 38.87K |
| Aug 6, 2026 | $2.00 | $2.1494 | $1.9562 | $2.02 | 39.82K |
| Aug 5, 2026 | $2.00 | $2.12 | $1.96 | $2.05 | 54.45K |
| Aug 4, 2026 | $2.00 | $2.15 | $1.95 | $2.04 | 54.79K |
| Aug 3, 2026 | $2.20 | $2.20 | $1.93 | $2.00 | 73.62K |
| Jul 31, 2026 | $2.30 | $2.34 | $2.10 | $2.15 | 70.48K |
| Jul 30, 2026 | $2.288 | $2.35 | $2.1815 | $2.23 | 34.51K |
| Jul 29, 2026 | $2.378 | $2.47 | $2.21 | $2.24 | 69.98K |
| Jul 28, 2026 | $2.36 | $2.44 | $2.10 | $2.39 | 86.99K |
| Jul 27, 2026 | $2.41 | $2.48 | $2.36 | $2.43 | 23.64K |
| Jul 24, 2026 | $2.64 | $2.75 | $2.35 | $2.36 | 57.96K |
| Jul 23, 2026 | $2.62 | $2.75 | $2.55 | $2.71 | 76.41K |
| Jul 22, 2026 | $2.55 | $2.75 | $2.52 | $2.64 | 90.95K |
| Jul 21, 2026 | $2.26 | $2.5887 | $2.26 | $2.58 | 68.97K |
| Jul 20, 2026 | $2.31 | $2.35 | $2.22 | $2.32 | 44.31K |
| Jul 17, 2026 | $2.29 | $2.32 | $2.21 | $2.26 | 53.18K |
| Jul 16, 2026 | $2.30 | $2.34 | $2.215 | $2.30 | 47.15K |
Latest MENS news
The latest Smart Investors Daily articles mentioning MENS.
Stock researchResearch & News · SEC Filings
Loading stock research…
